Cargando…
Prognostic sub-classification of intermediate-stage hepatocellular carcinoma: a multicenter cohort study with propensity score analysis
There is significant heterogeneity in the clinicopathological characteristics of intermediate hepatocellular carcinoma (IHCC). This also translates to treatment as transarterial chemoembolization (TACE) is used as first-line therapy for patients with IHCC; however, in Asia liver resection (LR) is pr...
Autores principales: | Ramaswami, Ramya, Pinato, David J., Kubota, Keiichi, Ishizuka, Mitsuru, Arizumi, Tadaaki, Kudo, Masatoshi, Jang, Jeong Won, Kim, Young Woon, Pirisi, Mario, Allara, Elias, Sharma, Rohini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013141/ https://www.ncbi.nlm.nih.gov/pubmed/27601241 http://dx.doi.org/10.1007/s12032-016-0827-8 |
Ejemplares similares
-
Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: a multi-center comparative study
por: Pinato, David J., et al.
Publicado: (2016) -
Correction: Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study
por: Hajiev, Saur, et al.
Publicado: (2021) -
Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study
por: Hajiev, Saur, et al.
Publicado: (2020) -
Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib
por: Howell, Jessica A., et al.
Publicado: (2017) -
Cold-inducible RNA-binding protein promotes the development of liver cancer
por: Sakurai, Toshiharu, et al.
Publicado: (2015)